Update to the AHA/ASA Recommendations for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Robert J. Adams(Adelaide Institute for Sleep Health), Lee H. Schwamm(Yale University), Karen L. Furie(Brown University), Philip B. Gorelick(Northwestern University), Gregory W. Albers(Stanford University), Robert E. Harbaugh(Penn State Milton S. Hershey Medical Center), Irene Katzan(Cleveland Clinic), Mark J. Alberts(Nanotherapeutics (United States)), Michael Marks(University of London), Oscar Benavente(University of British Columbia), Margaret Kelly‐Hayes(American Heart Association), Larry B. Goldstein(University of Kentucky), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), S. Claiborne Johnston(University of California, San Francisco), Ralph L. Sacco(University of Miami), Edgar J. Kenton(American Heart Association)
Cited by 480
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k